{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:58:01Z","timestamp":1770818281304,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01 MH100644"],"award-info":[{"award-number":["K01 MH100644"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA002925"],"award-info":[{"award-number":["R01 DA002925"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00213-016-4203-3","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T18:19:54Z","timestamp":1452709194000},"page":"1215-1225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents"],"prefix":"10.1007","volume":"233","author":[{"given":"Adam L.","family":"Halberstadt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Slepak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahalah R.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan B.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"4203_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fphar.2013.00109","volume":"4","author":"WK Adams","year":"2013","unstructured":"Adams WK, Halberstadt AL, van den Buuse M (2013) Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses. Front Pharmacol 4:109","journal-title":"Front Pharmacol"},{"key":"4203_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/syn.890080407","volume":"8","author":"HC Akunne","year":"1991","unstructured":"Akunne HC, Reid AA, Thurkauf A, Jacobson AE, de Costa BR, Rice KC, Heyes MP, Rothman RB (1991) [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex. Synapse 8:289\u2013300","journal-title":"Synapse"},{"key":"4203_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/BF00968412","volume":"17","author":"HC Akunne","year":"1992","unstructured":"Akunne HC, de Costa BR, Jacobson AE, Rice KC, Rothman RB (1992) [3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine. Neurochem Res 17:1275\u20131283","journal-title":"Neurochem Res"},{"key":"4203_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0014-2999(01)01340-1","volume":"431","author":"E Babar","year":"2001","unstructured":"Babar E, Ozg\u00fcnen T, Melik E, Polat S, Akman H (2001) Effects of ketamine on different types of anxiety\/fear and related memory in rats with lesions of the median raphe nucleus. Eur J Pharmacol 431:315\u2013320","journal-title":"Eur J Pharmacol"},{"key":"4203_CR5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-3565(25)23831-9","volume":"271","author":"VP Bakshi","year":"1994","unstructured":"Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787\u2013794","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-3565(24)38001-2","volume":"288","author":"VP Bakshi","year":"1999","unstructured":"Bakshi VP, Tricklebank M, Neijt HC, Lehmann-Masten V, Geyer MA (1999) Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. J Pharmacol Exp Ther 288:643\u2013652","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR7","first-page":"148","volume":"64","author":"RL Balster","year":"1986","unstructured":"Balster RL (1986) Clinical implications of behavioral pharmacology research on phencyclidine. NIDA Res Monogr 64:148\u2013162","journal-title":"NIDA Res Monogr"},{"key":"4203_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-3565(25)23493-0","volume":"249","author":"RL Balster","year":"1989","unstructured":"Balster RL (1989) Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline. J Pharmacol Exp Ther 249:749\u2013756","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1073\/pnas.83.1.189","volume":"83","author":"DK Bartschat","year":"1986","unstructured":"Bartschat DK, Blaustein MP (1986) Phencyclidine in low doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain. Proc Natl Acad Sci U S A 83:189\u2013192","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4203_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","volume":"67","author":"T Bast","year":"2000","unstructured":"Bast T, Zhang W, Feldon J, White IM (2000) Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats. Pharmacol Biochem Behav 67:647\u2013658","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pbb.2015.03.007","volume":"133","author":"CJ Botanas","year":"2015","unstructured":"Botanas CJ, de la Pe\u00f1a JB, Dela Pe\u00f1a IJ, Tampus R, Yoon R, Kim HJ, Lee YS, Jang CG, Cheong JH (2015) Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential. Pharmacol Biochem Behav 133:31\u201336","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1126\/science.6274022","volume":"215","author":"KT Brady","year":"1982","unstructured":"Brady KT, Balster RL, May EL (1982) Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats. Science 215:178\u2013180","journal-title":"Science"},{"key":"4203_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234\u2013258","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0091-3057(89)90020-8","volume":"32","author":"I Chaudieu","year":"1989","unstructured":"Chaudieu I, Vignon J, Chicheportiche M, Kamenka JM, Trouiller G et al (1989) Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs. Pharmacol Biochem Behav 32:699\u2013705","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hup.1242","volume":"27","author":"O Corazza","year":"2012","unstructured":"Corazza O, Schifano F, Simonato P, Fergus S, Assi S et al (2012) Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 27:145\u2013149","journal-title":"Hum Psychopharmacol"},{"key":"4203_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/cns.12063","volume":"19","author":"O Corazza","year":"2013","unstructured":"Corazza O, Assi S, Schifano F (2013) From \"Special K\" to \"Special M\": the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 19:454\u2013460","journal-title":"CNS Neurosci Ther"},{"key":"4203_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hup.2475","volume":"30","author":"CM Coyle","year":"2015","unstructured":"Coyle CM, Laws KR (2015) The use of ketamine as an antidepressant: a systematic review and meta-analysis. Hum Psychopharmacol 30:152\u2013163","journal-title":"Hum Psychopharmacol"},{"key":"4203_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/0091-3057(94)90506-1","volume":"48","author":"W Danysz","year":"1994","unstructured":"Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:118","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1023\/A:1006905106834","volume":"19","author":"VA Eterovi\u0107","year":"1999","unstructured":"Eterovi\u0107 VA, Lu R, Eakin AE, Rodr\u00edguez AD, Ferchmin PA (1999) Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ. Cell Mol Neurobiol 19:745\u2013757","journal-title":"Cell Mol Neurobiol"},{"key":"4203_CR20","doi-asserted-by":"crossref","unstructured":"Fuchigami Y, Fu X, Ikeda R, Kawakami S, Wada M, Kikura-Hanajiri R, Kuroda N, Nakashima K (2015) Evaluation of the neurochemical effects of methoxetamine using brain microdialysis in mice. Forensic Toxicol 1-6.","DOI":"10.1007\/s11419-015-0267-8"},{"key":"4203_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0091-3057(86)90266-2","volume":"25","author":"MA Geyer","year":"1986","unstructured":"Geyer MA, Russo PV, Masten VL (1986) Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 25:277\u2013288","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0091-3057(87)90460-6","volume":"28","author":"MA Geyer","year":"1987","unstructured":"Geyer MA, Russo PV, Segal DS, Kuczenski R (1987) Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacol Biochem Behav 28:393\u2013399","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117\u2013154","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00002826-199506000-00004","volume":"18","author":"AL Halberstadt","year":"1995","unstructured":"Halberstadt AL (1995) The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237\u2013249","journal-title":"Clin Neuropharmacol"},{"key":"4203_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0773.1995.tb01041.x","volume":"77","author":"O Hustveit","year":"1995","unstructured":"Hustveit O, Maurset A, Oye I (1995) Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol 77:355\u2013359","journal-title":"Pharmacol Toxicol"},{"key":"4203_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","volume":"69","author":"G Imre","year":"2006","unstructured":"Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ (2006) Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull 69:338\u2013345","journal-title":"Brain Res Bull"},{"key":"4203_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"4203_CR28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/schbul\/sbs069","volume":"38","author":"DC Javitt","year":"2012","unstructured":"Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D (2012) Has an angel shown the way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia. Schizophr Bull 38:958\u2013966","journal-title":"Schizophr Bull"},{"key":"4203_CR29","unstructured":"Keats AS, Telford J (1964) Narcotic antagonists as analgesics: clinical aspects. In: Gould RF (ed) Molecular modification in drug design, advances in chemistry series, vol 45. American Chemical Society, Washington, DC, pp. 170-176"},{"key":"4203_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF00310515","volume":"88","author":"AE Kelley","year":"1986","unstructured":"Kelley AE, Winnock M, Stinus L (1986) Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses. Psychopharmacology (Berl) 88:66\u201374","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/02791072.2013.803647","volume":"45","author":"A Kjellgren","year":"2013","unstructured":"Kjellgren A, Jonsson K (2013) Methoxetamine (MXE)\u2014a phenomenological study of experiences induced by a \u201clegal high\u201d from the internet. J Psychoactive Drugs 45:276\u2013286","journal-title":"J Psychoactive Drugs"},{"key":"4203_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0014-2999(97)01557-4","volume":"343","author":"K Krebs-Thomson","year":"1998","unstructured":"Krebs-Thomson K, Lehmann-Masten V, Naiem S, Paulus MP, Geyer MA (1998) Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. Eur J Pharmacol 343:135\u2013143","journal-title":"Eur J Pharmacol"},{"key":"4203_CR33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)24925-4","volume":"238","author":"BL Largent","year":"1986","unstructured":"Largent BL, Gundlach AL, Snyder SH (1986) Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238:739\u2013748","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/0028-3908(91)90083-N","volume":"30","author":"VD Lehmann-Masten","year":"1991","unstructured":"Lehmann-Masten VD, Geyer MA (1991) Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology 30:629\u2013636","journal-title":"Neuropharmacology"},{"key":"4203_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/SAR.S15458","volume":"2","author":"JH Li","year":"2011","unstructured":"Li JH, Vicknasingam B, Cheung YW, Zhou W, Nurhidayat AW, Jarlais DC, Schottenfeld R (2011) To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil 2:11\u201320","journal-title":"Subst Abuse Rehabil"},{"key":"4203_CR36","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.neuroimage.2006.05.022","volume":"32","author":"CL Littlewood","year":"2006","unstructured":"Littlewood CL, Cash D, Dixon AL, Dix SL, White CT, O\u2019Neill MJ, Tricklebank M, Williams SC (2006) Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat. Neuroimage 32:1733\u20131746","journal-title":"Neuroimage"},{"key":"4203_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"ED Luby","year":"1959","unstructured":"Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81:363\u2013369","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"4203_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","volume":"2","author":"RS Mansbach","year":"1989","unstructured":"Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299\u2013308","journal-title":"Neuropsychopharmacology"},{"key":"4203_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF02244303","volume":"105","author":"RS Mansbach","year":"1991","unstructured":"Mansbach RS, Geyer MA (1991) Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine. Psychopharmacology (Berl) 105:162\u2013168","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0091-3057(89)90500-5","volume":"33","author":"SH Marglin","year":"1989","unstructured":"Marglin SH, Milano WC, Mattie ME, Reid LD (1989) PCP and conditioned place preferences. Pharmacol Biochem Behav 33:281\u2013283","journal-title":"Pharmacol Biochem Behav"},{"key":"4203_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00442246","volume":"97","author":"KL Marquis","year":"1989","unstructured":"Marquis KL, Webb MG, Moreton JE (1989) Effects of fixed ratio size and dose on phencyclidine self-administration by rats. Psychopharmacology (Berl) 97:179\u2013182","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR42","first-page":"94","volume":"64","author":"A Mattia","year":"1986","unstructured":"Mattia A, Leccese AP, Marquis KL, el-Fakahany EE, Moreton JE (1986) Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'. NIDA Res Monogr 64:94\u2013111","journal-title":"NIDA Res Monogr"},{"key":"4203_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.1991.tb08185.x","volume":"56","author":"T Maurice","year":"1991","unstructured":"Maurice T, Vignon J, Kamenka JM, Chicheportiche R (1991) Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J Neurochem 56:553\u2013559","journal-title":"J Neurochem"},{"key":"4203_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00005053-195907000-00006","volume":"129","author":"JS Meyer","year":"1959","unstructured":"Meyer JS, Greifenstein F, Devault M (1959) A new drug causing symptoms of sensory deprivation: neurological, electroencephalographic and pharmalogical effects of Sernyl. J Nerv Ment Dis 129:54\u201361","journal-title":"J Nerv Ment Dis"},{"key":"4203_CR45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3565(25)31050-5","volume":"203","author":"JE Moreton","year":"1977","unstructured":"Moreton JE, Meisch RA, Stark L, Thompson T (1977) Ketamine self-administration by the rhesus monkey. J Pharmacol Exp Ther 203:303\u2013309","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6:614\u2013632","journal-title":"Drug Test Anal"},{"key":"4203_CR47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)11430-4","volume":"260","author":"I Oye","year":"1992","unstructured":"Oye I, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209\u20131213","journal-title":"J Pharmacol Exp Ther"},{"key":"4203_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000321803","volume":"63","author":"T P\u00e1len\u00ed\u010dek","year":"2011","unstructured":"P\u00e1len\u00ed\u010dek T, Fuj\u00e1kov\u00e1 M, Brunovsk\u00fd M, Bal\u00edkov\u00e1 M, Hor\u00e1\u010dek J, Gorman I, Tyl\u0161 F, Ti\u0161lerov\u00e1 B, So\u0161 P, Buben\u00edkov\u00e1-Vale\u0161ov\u00e1 V, H\u00f6schl C, Kraj\u010da V (2011) Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology 63:202\u2013218","journal-title":"Neuropsychobiology"},{"key":"4203_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02244547","volume":"104","author":"MP Paulus","year":"1991","unstructured":"Paulus MP, Geyer MA (1991) A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology (Berl) 104:6\u201316","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR50","first-page":"15","volume":"7","author":"MP Paulus","year":"1992","unstructured":"Paulus MP, Geyer MA (1992) The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15\u201331","journal-title":"Neuropsychopharmacology"},{"key":"4203_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/7854_2011_195","volume":"12","author":"SB Powell","year":"2012","unstructured":"Powell SB, Weber M, Geyer MA (2012) Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci 12:251\u2013318","journal-title":"Curr Top Behav Neurosci"},{"key":"4203_CR52","doi-asserted-by":"publisher","first-page":"e59334","DOI":"10.1371\/journal.pone.0059334","volume":"8","author":"BL Roth","year":"2013","unstructured":"Roth BL, Gibbons S, Arunotayanun W, Huang XP, Setola V, Treble R, Iversen L (2013) The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS ONE 8:e59334","journal-title":"PLoS ONE"},{"key":"4203_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/026988118900300402","volume":"3","author":"DJ Sanger","year":"1989","unstructured":"Sanger DJ, Zivkovic B (1989) The discriminative stimulus effects of MK-801: generalization to other N-methyl-D-aspartate receptor antagonists. J Psychopharmacol 3:198\u2013204","journal-title":"J Psychopharmacol"},{"key":"4203_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0014-2999(82)90207-2","volume":"84","author":"HE Shannon","year":"1982","unstructured":"Shannon HE (1982) Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats. Eur J Pharmacol 84:225\u2013228","journal-title":"Eur J Pharmacol"},{"key":"4203_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-2999(82)90506-4","volume":"82","author":"GT Shearman","year":"1982","unstructured":"Shearman GT, Herz A (1982) Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. Eur J Pharmacol 82:167\u2013172","journal-title":"Eur J Pharmacol"},{"key":"4203_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","volume":"5","author":"JS Silvestre","year":"1997","unstructured":"Silvestre JS, Nadal R, Pallar\u00e9s M, Ferr\u00e9 N (1997) Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5:29\u201333","journal-title":"Depress Anxiety"},{"key":"4203_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","volume":"59","author":"RD Sturgeon","year":"1979","unstructured":"Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169\u2013179","journal-title":"Eur J Pharmacol"},{"key":"4203_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-2999(99)00762-1","volume":"385","author":"T Suzuki","year":"1999","unstructured":"Suzuki T, Aoki T, Kato H, Yamazaki M, Misawa M (1999) Effects of the 5-HT3 receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice. Eur J Pharmacol 385:99\u2013102","journal-title":"Eur J Pharmacol"},{"key":"4203_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-2999(85)90536-9","volume":"109","author":"SW Tam","year":"1985","unstructured":"Tam SW (1985) (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, \u03bc, \u03ba, \u03b4 and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol 109:33\u201341","journal-title":"Eur J Pharmacol"},{"key":"4203_CR60","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ilar.52.3.366","volume":"52","author":"KA Trujillo","year":"2011","unstructured":"Trujillo KA, Smith ML, Sullivan B, Heller CY, Garcia C, Bates M (2011) The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders. ILAR J 52:366\u2013378","journal-title":"ILAR J"},{"key":"4203_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/026988119400800302","volume":"8","author":"GB Varty","year":"1994","unstructured":"Varty GB, Higgins GA (1994) Differences between three rat strains in sensitivity to prepulse inhibition of an acoustic startle response: influence of apomorphine and phencyclidine pretreatment. J Psychopharmacol 8:148\u2013156","journal-title":"J Psychopharmacol"},{"key":"4203_CR62","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","volume":"56","author":"FX Vollenweider","year":"2001","unstructured":"Vollenweider FX, Geyer MA (2001) A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 56:495\u2013507","journal-title":"Brain Res Bull"},{"key":"4203_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","volume":"7","author":"FX Vollenweider","year":"1997","unstructured":"Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J (1997) Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7:25\u201338","journal-title":"Eur Neuropsychopharmacol"},{"key":"4203_CR64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0031-6997(25)00047-X","volume":"42","author":"JM Walker","year":"1990","unstructured":"Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355\u2013402","journal-title":"Pharmacol Rev"},{"key":"4203_CR65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00213-002-1297-6","volume":"165","author":"JL Wiley","year":"2003","unstructured":"Wiley JL, Harvey SA, Balster RL, Nicholson KL (2003) Affinity and specificity of N-methyl-D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats. Psychopharmacology (Berl) 165:378\u2013385","journal-title":"Psychopharmacology (Berl)"},{"key":"4203_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1749-6632.1988.tb42109.x","volume":"537","author":"RA Wise","year":"1988","unstructured":"Wise RA (1988) Psychomotor stimulant properties of addictive drugs. Ann N Y Acad Sci 537:228\u2013234","journal-title":"Ann N Y Acad Sci"},{"key":"4203_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469\u2013492","journal-title":"Psychol Rev"},{"key":"4203_CR68","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","volume":"83","author":"EH Wong","year":"1986","unstructured":"Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 83:7104\u20137108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4203_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0006-8993(84)91326-X","volume":"294","author":"SR Zukin","year":"1984","unstructured":"Zukin SR, Brady KT, Slifer BL, Balster RL (1984) Behavioral and biochemical stereoselectivity of sigma opiate\/PCP receptors. Brain Res 294:174\u2013177","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4203-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4203-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T03:46:26Z","timestamp":1748749586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["4203"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4203-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]},"assertion":[{"value":"22 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Halberstadt\u2019s work has been funded by NIH, the Brain & Behavior Research Foundation, and L-3 Communications. Dr. Powell\u2019s work has been funded by NIH and Acadia Pharmaceuticals. Mahalah Buell, James Hyun, and Natasha Slepak have not received compensation for professional services during the past 3\u00a0years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}